Drug recall · February 27, 2019
Mometasone Furoate Cream recall
Why: Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc. South Plainfield, NJ 07080, NDC 0713-0726-37
- Lots / codes
Lot #: 1009431, 1009507, Exp. 08/2020; 1009886, Exp. 09/2020
- Quantity
- 58,176 units
- Company
- ACP Nimble Buyer, Inc., South Plainfield, NJ
- Distribution
- Nationwide within the United States
- Initiated
- February 7, 2019 · Voluntary: Firm initiated
- Classified
- February 20, 2019
- Reported
- February 27, 2019
- Ended
- March 23, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mometasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.